THE Coffin-Lowry syndrome (CLS), an X-linked disorder, is characterize
d by severe psychomotor retardation, facial and digital dysmorphisms,
and progressive skeletal deformations(1). Genetic linkage analysis map
ped the CLS locus to an interval of 2-3 megabases at Xp22.2. The gene
coding for Rsk-2, a member of the growth-factor-regulated protein kina
ses, maps within the candidate interval, and was tested as a candidate
gene for CLS. Initial screening for mutations in the gene for Rsk-2 i
n 76 unrelated CLS patients revealed one intragenic deletion, a nonsen
se, two splice site, and two missense mutations. The two missenses aff
ect sites critical for the function of Rsk-2. The mutated Rsk-2 protei
ns were found to be inactive in a S6 kinase assay. These findings prov
ide direct evidence that abnormalities in the MAPK/RSK signalling path
way cause Coffin-Lowry syndrome.